Saturday 17 October 2026
Export BPTH’s income statement to Excel — free account
Bio-Path Holdings, Inc.
BPTH Healthcare Biotechnology
In the quarter to March 2026, EPS fell 101.2% and free cash flow grew 98.7%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
0.00
0.00
NaN
Follow BPTH
| Mar '26 | Dec '25 | Sep '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
Current Ratio |
0.07 | 0.08 | 0.08 | 0.09 |
+8 more quarters Free account |
Net Debt/EBITDA |
0.04 | — | 0.00 | 0.00 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.14 | — | 0.00 | 0.06 | |
Capex/Depreciation |
0.00 | — | 0.00 | 0.00 | |
Interest Coverage |
(11.88) | — | (3.75) | (130.34) | |
Research and Development Expense of Revenue |
0.00% | — | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | — | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | — | 0.00% | 0.00% | |
Free Cash Flow per Share |
0.00 | — | 0.00 | (0.03) | |
Cash per Share |
0.00 | — | 0.00 | 0.00 | |
Shareholders Equity per Share |
(0.91) | 0.00 | (0.94) | (0.86) | |
Interest Debt per Share |
0.00 | — | 0.00 | 0.00 | |
Book value per Share |
(0.91) | 0.00 | (0.94) | (0.86) | |
Free Cash Flow |
(0.04) | — | 0.00 | (0.28) | |
Working Capital |
(8.47) | (8.22) | (8.02) | (7.18) | |
Net Current Asset Value |
(8.49) | (8.23) | (8.03) | (7.22) | |
| Other line items | |||||
Quick Ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.00 | — | 0.00 | 0.00 | |
Operating CF per Share |
0.00 | — | 0.00 | (0.03) | |
Capex per Share |
0.00 | — | 0.00 | 0.00 | |
Average Payables |
3.80 | 3.09 | 2.97 | 2.12 | |
Average Assets |
1.44 | 2.28 | 1.83 | 2.93 | |
Average Common Equity |
(5.54) | (4.03) | (4.36) | (2.93) |
Columns are period end dates